Cleveland Clinic is comprised of a 1,400-bed academic medical center and 17 additional hospitals, including 5 in Southeast Florida. In total, there are nearly 6,000 inpatient beds and over 1,400 pharmacy employees, more than 300 physician practices, 20 ambulatory pharmacies, significant inpatient and outpatient clinical services and a pharmacy budget exceeding $1 billion.
The Pharmacotherapy Residency (PGY-1 and PGY-2) is a specialized two-year training program designed to develop expert-level competence in pharmacotherapy.
The program instructs the resident on the provision of safe, appropriate, economical use of medication through the application of specialized knowledge, skills and functions in patient care in preparation for becoming a board-certified pharmacotherapy specialist (BCPS). The program’s goal is to develop an expert-level practitioner with the necessary knowledge, skills and abilities to thrive as a clinical generalist, specialist, coordinator or faculty member. Rotations are arranged in two-to three-month long clinical blocks that focus on a particular area of pharmacotherapy (e.g., critical care, internal medicine, pediatrics). In the second year, more specialized blocks of clinical rotations and a longitudinal ambulatory care component are offered to build and enhance competencies acquired during the resident’s first year.
Residents also have the opportunity to concentrate on a particular area of pharmacotherapy in the second year. Throughout year 1 and 2, additional requirements include presentations, projects, a manuscript, and inpatient staffing.
CONTACT Pharmacotherapy Residency Director Michael A. Militello, PharmD, BCPS Cleveland Clinic Department of Pharmacy 9500 Euclid Ave. HB 105, Cleveland, Ohio 44195 email: email@example.com
Interested applicants must be PharmD graduates of accredited college of pharmacy, be eligible for licensure in the State of Ohio and submit the standard application materials through PhORCAS.
Please submit all application materials via Pharmacy Online Residency Centralized Application Service (PhORCAS). Deadline for receipt of these materials to be considered for an on-site interview is January 1, 2020 by 11:59 PM. Cleveland Clinic Health-System Residency sites agree that no person at these sites will solicit, accept, or use any ranking-related information from any residency applicant.
NOTE: 1. Residency applicants must currently be authorized to work in the United States. Cleveland Clinic Pharmacy does not sponsor applicants for work Visas. 2. Appointments of applicants to residency positions may be contingent upon the applicants satisfying certain eligibility requirements [e.g., graduating from accredited college of pharmacy, obtaining pharmacist license in Ohio (for Ohio sites) or Florida (for Florida sites) within 90 days of start date, and successful completion of a pre-employment physical and drug screen, including testing for cotinine]. 3. Unfortunately, we cannot accommodate OPT (Optional Practical Training) Visas for the Cleveland Clinic Pharmacy Residency Program as the program extends beyond 12 months. 4. The Cleveland Clinic Pharmacy Residency Program does not meet the qualifications of an OPT STEM employer because Cleveland Clinic is not enrolled in E-Verify.
Internal Number: 2
About Cleveland Clinic Main Campus
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. We are ranked among the nation’s top hospitals by U.S.News & World Report. That’s why people from across the country and around the world come here for care. A teaching and research leader, we offer exceptional career opportunities, as well as access to cutting-edge technology and innovative medical ideas.